VXRTOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Vaxart, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$0.48+0.02 (+5.04%)
Close on Oct 19, 2026
- Market cap
- $115.15M
- P/E (TTM)
- 3.2
- Dividend yield
- –
Charting library not installed
Copy the licensed TradingView charting_library folder to apps/web/public/charting_library/, or set TV_LIBRARY_PATH, then reload. Setup steps are in docs/ADVANCED-CHARTS.md.